The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Differences in cancer incidence by broad ethnic group in England, 2013–2017
Open accessAbstract
Background: Cancer incidence variation between population groups can inform public health and cancer services. Previous studies have shown cancer incidence rates vary by ethnic group in England. Since their publication, the completeness of ethnicity recording in cancer data has improved, and relevant inequalities (e.g. risk factor prevalence and healthcare access) may have changed. Methods: Age-standardised incidence rates were calculated for Asian, Black, Mixed/Multiple and White ethnic groups in England in 2013–2017, using almost 3 million diagnoses across 31 cancer sites. Rate ratios were calculated with the White ethnic group as reference. Sensitivity analyses used imputed ethnicity for cases with missing data and perturbed population estimates. Results: Incidence rates for most cancer sites and ethnic group and sex combinations were lower in non-White minority ethnic groups compared with the corresponding White group, with particularly low rate ratios (below 0.5) for melanoma skin cancer and some smoking-related cancers (lung, bladder and oesophageal cancers). Exceptions included prostate cancer (2.1 times higher in males of Black ethnicity), myeloma (2.7–3.0 times higher in people of Black ethnicity), several gastrointestinal cancers (1.1–1.9 times higher in people of Black ethnicity, 1.4–2.2 times higher in people of Asian ethnicity), Hodgkin lymphoma (1.1 times higher in males of Asian ethnicity, 1.3 times higher in males of Black ethnicity) and thyroid cancers (1.4 times higher in people of Asian ethnicity, 1.2 times higher in people of Black ethnicity). Sensitivity analyses did not materially alter these results (rate ratios changed by a maximum of 12 percentage points, the direction and significance of results were unchanged in all but two cancer site/sex/ethnic group combinations). Conclusions: People of non-White minority ethnicity in England generally have lower cancer risk than the White population, though there are a number of notable exceptions. These results should galvanise efforts to better understand the reasons for this variation, and the possible impact on cancer services, patient experiences and outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Yet, multiple sources indicate that in some diseases, such as cancer, the incidence and mortality rates tend to be lower among White ethnic groups in the UK compared to other groups [21–23].”
From Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review (2025) · cites this paper as [22]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
Hooi, J. K. Y., Lai, W. Y., Ng, W. K., Suen, M. M. Y., Underwood, F. E., Tanyingoh, D., Malfertheiner, P., Graham, D. Y., Wong, V. W., Wu, J. C., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.022 · Cited by 3,391
International Agency for Research on Cancer (IARC)
(2018) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-94186-5_629 · Cited by 2,796
Turra, C. M., & Elo, I. T. (2008) · Population Research and Policy Review · doi:10.1007/s11113-008-9087-4 · Cited by 385
Cultural Issues in Medication Adherence: Disparities and Directions
McQuaid, E. L., & Landier, W. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-017-4199-3 · Cited by 326
Cancer risk diversity in non-western migrants to Europe: An overview of the literature
Arnold, M., Razum, O., & Coebergh, J. W. W. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.050 · Cited by 196
The effectiveness of NHS smoking cessation services: a systematic review
Bauld, L., Bell, K., McCullough, L. B., Richardson, L., & Greaves, L. (2009) · Journal of Public Health · doi:10.1093/pubmed/fdp074 · Cited by 184
Nierkens, V., Hartman, M. A., Nicolaou, M., Vissenberg, C., Beune, E., Hosper, K., van Valkengoed, I. G. M., & Stronks, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073373 · Cited by 176
Rapid review of evaluation of interventions to improve participation in cancer screening services
Duffy, S. W., Myles, J. P., Maroni, R., & Mohammad, A. (2016) · Journal of Medical Screening · doi:10.1177/0969141316664757 · Cited by 165
Szczepura, A. K., Price, C., & Gumber, A. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-346 · Cited by 158
Saunders, C. L., Abel, G., Turabi, A. E., Ahmed, F., & Lyratzopoulos, G. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002882 · Cited by 134
Cited by
Sorted by citations
Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors
Jubber, I., Ong, S., Bukavina, L., Black, P. C., Compérat, É., Kamat, A. M., Kiemeney, L. A. L. M., Lawrentschuk, N., Lerner, S. P., Meeks, J. J., et al. (2023) · European Urology · doi:10.1016/j.eururo.2023.03.029 · Cited by 549
Barlow, M., Down, L., Mounce, L. T. A., Merriel, S. W., Watson, J., Martins, T., & Bailey, S. E. R. (2022) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-022-00613-7 · Cited by 58
Surgical health policy 2025–35: strengthening essential services for tomorrow's needs
Nepogodiev, D., Picciochi, M., Ademuyiwa, A. O., Adisa, A., Agbeko, A. E., Aguilera, M. L., Agyei, F., Alexander, P. V., Henry, J. C. A., Anyomih, T. T. K., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00985-7 · Cited by 62
Kalsi, D., Thomas, L., Hyde, C., Dan, M., Greenhalgh, J., & Ko, J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1264846 · Cited by 53
Moss, E. L., Taylor, A., Andreou, A., Ang, C., Arora, R., Attygalle, A. D., Banerjee, S. N., Bowen, R. L., Buckley, L., Burbos, N., et al. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.06.025 · Cited by 49
Metadata
- Authors
- Delon, C., Brown, K. F., Payne, N. W. S., Kotrotsios, Y., Vernon, S., & Shelton, J.
- Affiliations
- Cancer Research UK (GB)
- NHS Digital (GB)
- Corresponding author
- Delon, Christine
- Venue
- British Journal of Cancer
- Published
- 2022-03-02
- Volume
- 126
- Issue
- 12
- Pages
- 1765-1773
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC9174248
- OpenAlex
- W4214903413
- Cited by
- 137
- References
- 54
- Citations by year
- 2026: 22 · 2025: 43 · 2024: 40 · 2023: 24 · 2022: 8
- FWCI
- 12.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- British Journal of Cancer (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Social Sciences › Health › Health disparities and outcomes
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Keywords
- cancer incidence, ethnic disparities, ethnic minorities, Asian ethnicity, Black ethnicity, melanoma, tobacco-related cancer, prostate cancer, multiple myeloma, Hodgkin's disease, thyroid cancer, gastrointestinal cancer, lung cancer, bladder cancer, esophageal cancer, England
- MeSH terms
- Ethnicity, Gastrointestinal Neoplasms, Humans, Male, Minority Groups, Risk Factors, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
